Agile Therapeutics (AGXRW) 10-K 2015 FY Annual report

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

        We consent to the incorporation by reference in the Registration Statements:

(1)

Registration Statement (Form S-8 No. 333-199441), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,



(2)

Registration Statement (Form S-3 No. 333-205120) of Agile Therapeutics, Inc. and



(3)

Registration Statement (Form S-8 No. 333-205116), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,

of our report dated March 9, 2016 with respect to the financial statements of Agile Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2015.

/s/ Ernst & Young LLP

Metro Park, New Jersey
March 9, 2016

QuickLinks

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm